Pallidotomy for Parkinson's disease: hitting the target?

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Neurology·2008

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

Neurology·2006

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study.

Neurology·2005

Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.

Movement disorders : official journal of the Movement Disorder Society·2005

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.

Neurology·2003

Segregation analysis of Parkinson disease revealing evidence for a major causative gene.

American journal of medical genetics·2002

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Methodological considerations for designing and conducting open-label placebo trials.

Pain·2026

Efficacy of intravenous ketamine for neuropathic pain: a systematic review and meta-analysis of randomized clinical trials.

Pain management·2026

Data-driven in silico toxicity profiling of marketed drugs and retrospective analysis of post-marketing withdrawal risk.

Toxicology mechanisms and methods·2026

Influence of sex, anxiety, and risk-taking behavior on opioid and alcohol polysubstance consumption patterns.

Addiction neuroscience·2026

Assessing the Safety of Medications During Lactation: Lactation safety.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026

Timing of Intraoperative Dexmedetomidine Administration and Post-anaesthesia Care Unit Recovery: A Single-Centre Quality Improvement Audit.

Cureus·2026

Related Experiment Videos

Pallidotomy for Parkinson's disease: hitting the target?

Related Concept Videos

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study.

Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.

Segregation analysis of Parkinson disease revealing evidence for a major causative gene.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Methodological considerations for designing and conducting open-label placebo trials.

Efficacy of intravenous ketamine for neuropathic pain: a systematic review and meta-analysis of randomized clinical trials.

Data-driven in silico toxicity profiling of marketed drugs and retrospective analysis of post-marketing withdrawal risk.

Influence of sex, anxiety, and risk-taking behavior on opioid and alcohol polysubstance consumption patterns.

Assessing the Safety of Medications During Lactation: Lactation safety.

Timing of Intraoperative Dexmedetomidine Administration and Post-anaesthesia Care Unit Recovery: A Single-Centre Quality Improvement Audit.

Related Experiment Videos

Pallidotomy for Parkinson's disease: hitting the target?

Related Concept Videos

Related Articles